Development of a universal benefit-risk assessment framework and its application for regulatory agencies
The assessment of medicines has moved from efficacy and safety to that of a benefit-risk balance and regulatory agencies and pharmaceutical companies are improving their processes in order to achieve greater consistency and transparency in decision-making. However, their efforts are largely independ...
| Main Author: | |
|---|---|
| Published: |
Cardiff University
2013
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.600591 |